We hypothesized that o-fluoro-L-p-boronophenylalanine (L-18FPBA) PET/MR could provide more
precise treatment planning for Boron neutron capture therapy (BNCT) compared
with L-18FBPA PET/CT. We implemented the phantom trial to measure the radioactivity
correlation between PET/CT and PET/MR. Results have high comparability. We
accessed patients who were potentially eligible for BNCT with same paradigms.
The initial results represented acceptable correlation between these two modalities.
Furthermore, because of high sensitivity and sophisticated imaging resolution,
medics can easy to organize the more accurate treatment planning. In
conclusion, PET/MR provides comparable L-18FBPA quantitative measurement and more
diagnostic accuracy than PET/CT.